Literature DB >> 2133217

Cellular regulation of tissue factor.

J P Brozna1.   

Abstract

Tissue factor is the initiator of the extrinsic coagulation pathway and is an important regulator of haemostasis. Tissue factor is constitutively expressed in numerous cells and tissues, and can be induced in monocytes and endothelial cells by different inflammatory agents. Lymphocytes and serum factors can modulate the expression of tissue factor in monocytes. The regulation of tissue factor expression in monocytes appears to be different from that in endothelial cells. Phorbol myristate acetate can inhibit as well as induce tissue factor activity in monocytes, whereas phorbol myristate acetate only induces the expression of tissue factor in endothelial cells. Tissue factor expression in monocytes from patients with infections is not always associated with DIC. The extrinsic pathway inhibitor may play a role in the development of DIC in patients with sepsis. Deposition of extravascular fibrin may be an important determinant of tissue injury.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2133217     DOI: 10.1097/00001721-199010000-00009

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  10 in total

1.  Tissue factor inflammatory response regulated by promoter genotype and p38 MAPK in neonatal vs. adult microvascular endothelial cells.

Authors:  Jeffrey S Buzby; Shirley A Williams; Karen L Imfeld; Thomas J Kunicki; Diane J Nugent
Journal:  Inflamm Res       Date:  2014-01-03       Impact factor: 4.575

2.  Prostate Cancer - Old Problems and New Approaches. (Part II. Diagnostic and Prognostic Markers, Pathology and Biological Aspects).

Authors:  Kenneth V Honn; Amer Aref; Yong Q Chen; Michael L Cher; John D Crissman; Jeffrey D Forman; Xiang Gao; David Grignon; Maha Hussain; Arthur T Porter; Edson J Pontes; Bruce Redman; Wael Sakr; Richard Severson; Dean G Tang; David P Wood
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

3.  Coagulopathy in the prostate cancer patient: prevalence and clinical relevance.

Authors:  A S Adamson; J L Francis; R O Witherow; M E Snell
Journal:  Ann R Coll Surg Engl       Date:  1993-03       Impact factor: 1.891

4.  Immunohistochemical study of tissue factor expression in normal intestine and idiopathic inflammatory bowel disease.

Authors:  L More; R Sim; M Hudson; A P Dhillon; R Pounder; A J Wakefield
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

5.  The cytoplasmic domain of tissue factor contributes to leukocyte recruitment and death in endotoxemia.

Authors:  Laveena Sharma; Els Melis; Michael J Hickey; Colin D Clyne; Jonathan Erlich; Levon M Khachigian; Piers Davenport; Eric Morand; Peter Carmeliet; Peter G Tipping
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

6.  Hyperfibrinolysis during intracranial surgery: effect of high dose aprotinin.

Authors:  J D Palmer; D A Francis; O S Roath; J L Francis; F Iannotti
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-01       Impact factor: 10.154

Review 7.  Is the neutrophil a 'prima donna' in the procoagulant process during sepsis?

Authors:  Toshiaki Iba; Takahiro Miki; Naoyuki Hashiguchi; Yoko Tabe; Isao Nagaoka
Journal:  Crit Care       Date:  2014-07-09       Impact factor: 9.097

8.  Interaction of von Willebrand factor with blood cells in flow models: a systematic review.

Authors:  Ryanne A Arisz; Judith J de Vries; Saskia E M Schols; Jeroen C J Eikenboom; Moniek P M de Maat
Journal:  Blood Adv       Date:  2022-07-12

9.  Procoagulant activity may be a marker of the malignant phenotype in experimental prostate cancer.

Authors:  A S Adamson; P Luckert; M Pollard; M E Snell; M Amirkhosravi; J L Francis
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

Review 10.  Role of extracellular vesicles in the development of sepsis-induced coagulopathy.

Authors:  Toshiaki Iba; Hiroshi Ogura
Journal:  J Intensive Care       Date:  2018-10-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.